Trial intelligence / Profile preview

Influence of Sirolimus and MMF on Vascular Function in Renal Transplant Recipients

NCT00204321Phase 4Completed

Sponsor
Universitätsklinikum Münster
Start
Jun 2005
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of sirolimus and mycophenolate mofetil in kidney transplant rejection, sponsored by Universitätsklinikum Münster. Primary endpoints: Distensibility, Sympathetic nervous system activity and 1 more. Started Jun 2005; status: completed.

02

Drugs

sirolimusmycophenolate mofetil
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00204321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00204321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call